ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.96
0.84%
US Tech 100
21,078.00
-0.43%
S&P 500
6,066.44
0.67%
US Dollar vs CAD
1.43366
0.00%
Bitcoin
98,024.86
0.56%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. FibroGen Inc (FGEN)

  7. FibroGen Inc (FGEN) News

FGEN

FibroGen (FGEN)

FibroGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:FGEN
DateTimeSourceHeadlineSymbolCompany
01/10/20255:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
12/18/20244:01PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
12/16/20248:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
12/16/20247:05AMGlobeNewswire Inc.FibroGen Appoints David DeLucia as Chief Financial OfficerNASDAQ:FGENFibroGen Inc
12/09/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
12/09/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
12/09/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
11/14/20243:52PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FGENFibroGen Inc
11/12/20243:10PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FGENFibroGen Inc
11/12/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
11/12/20243:05PMGlobeNewswire Inc.FibroGen Reports Third Quarter 2024 Financial ResultsNASDAQ:FGENFibroGen Inc
11/04/20243:05PMGlobeNewswire Inc.FibroGen to Report Third Quarter 2024 Financial ResultsNASDAQ:FGENFibroGen Inc
10/03/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
09/16/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
09/13/20243:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
09/09/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
09/09/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
09/09/20247:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
09/06/20243:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
09/03/20243:05PMGlobeNewswire Inc.FibroGen to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FGENFibroGen Inc
08/07/20244:10PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FGENFibroGen Inc
08/07/20244:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
08/06/20243:11PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FGENFibroGen Inc
08/06/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:FGENFibroGen Inc
08/06/20243:05PMGlobeNewswire Inc.FibroGen Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:FGENFibroGen Inc
08/05/20243:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FGENFibroGen Inc
07/30/20243:07PMGlobeNewswire Inc.FibroGen to Report Second Quarter 2024 Financial ResultsNASDAQ:FGENFibroGen Inc
07/30/20243:05PMGlobeNewswire Inc.FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate UpdateNASDAQ:FGENFibroGen Inc
07/10/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FGENFibroGen Inc
07/08/20243:32PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:FGENFibroGen Inc
 Showing the most relevant articles for your search:NASDAQ:FGEN

Your Recent History

USOTC
TPTW
TPT Global Tech (CE)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
TSXV
SEV
Spectra7 Microsystems
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
FDCT
FDCTech (PK)
USOTC
GCAN
Greater Cannabis (PK)
USOTC
MONI
Moon Equity (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
SMCI
Super Micro Computer
USOTC
VXIT
Virexit Technologies (PK)
USOTC
VDRM
ViaDerma (PK)
NASDAQ
NXPL
NextPlat
USOTC
MCIC
Multicorp (PK)
NYSE
IONQ
IonQ
NASDAQ
NVDA
NVIDIA
USOTC
BIEL
Bioelectronics (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads